PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.46 Cr | ₹0.94 Cr | ₹2.74 Cr | ₹2.74 Cr | ₹0.73 Cr |
What is the latest Contingent Liabilities ratio of PARNAX LAB ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.46 Cr |
| Mar2024 | ₹0.94 Cr |
| Mar2023 | ₹2.74 Cr |
| Mar2022 | ₹2.74 Cr |
| Mar2021 | ₹0.73 Cr |
How is Contingent Liabilities of PARNAX LAB Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.46 Cr | 56.14 | |
| Mar2024 | ₹0.94 Cr | -65.84 | |
| Mar2023 | ₹2.74 Cr | 0.00 | |
| Mar2022 | ₹2.74 Cr | 274.73 | |
| Mar2021 | ₹0.73 Cr | - | |
Compare Contingent Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹165.7 Cr | 5.9% | 18.3% | 32.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 5.9% |
18.3% |
32.6% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses